Lataa...
Mechanisms of tolvaptan-induced toxicity in HepG2 cells()
Tolvaptan, a vasopressin receptor 2 antagonist used to treat hyponatremia, has recently been reported to be associated with an increased risk of liver injury. In this study, we explored the underlying mechanisms of hepatotoxicity of tolvaptan using human HepG2 cells. Tolvaptan inhibited cell growth...
Tallennettuna:
| Julkaisussa: | Biochem Pharmacol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5894093/ https://ncbi.nlm.nih.gov/pubmed/25858412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2015.03.015 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|